Tilray Inc (NASDAQ:TLRY – Get Free Report) traded up 2.4% on Monday . The company traded as high as $1.71 and last traded at $1.70. 3,617,128 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 27,686,580 shares. The stock had previously closed at $1.66.
Analysts Set New Price Targets
A number of research analysts have commented on the company. CIBC decreased their price objective on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 10th. Canaccord Genuity Group decreased their price target on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Finally, Alliance Global Partners boosted their price objective on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a report on Friday, April 5th.
Read Our Latest Report on TLRY
Tilray Trading Up 4.3 %
Hedge Funds Weigh In On Tilray
A number of hedge funds and other institutional investors have recently made changes to their positions in TLRY. SG Americas Securities LLC lifted its holdings in Tilray by 56.7% during the fourth quarter. SG Americas Securities LLC now owns 415,413 shares of the company’s stock worth $955,000 after acquiring an additional 150,247 shares in the last quarter. Gotham Asset Management LLC grew its position in shares of Tilray by 1,038.7% in the 3rd quarter. Gotham Asset Management LLC now owns 1,168,774 shares of the company’s stock valued at $2,793,000 after purchasing an additional 1,066,137 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Tilray during the 3rd quarter worth approximately $2,023,000. Public Sector Pension Investment Board raised its holdings in Tilray by 11.4% during the 3rd quarter. Public Sector Pension Investment Board now owns 1,519,415 shares of the company’s stock worth $3,630,000 after buying an additional 155,672 shares during the period. Finally, Redhawk Wealth Advisors Inc. bought a new position in Tilray in the fourth quarter valued at approximately $38,000. 9.35% of the stock is owned by institutional investors.
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More
- Five stocks we like better than Tilray
- How to Invest in Small Cap Stocks
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- What is Put Option Volume?
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- Golden Cross Stocks: Pattern, Examples and Charts
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.